Any effective vaccine will take over a year to be developed and ready to be brought to bear on the coronavirus outbreak on a large scale, the UK-led team argued.

As coronavirus pandemic deepens, over 117 million children in 37 countries are expected to miss out on receiving live-saving measles vaccine, the United Nations said on Tuesday.Measles immunisation campaigns in 24 countries have already been delayed and more will be postponed, the World Health Organization and the UN children's fund UNICEF said."Together, more than 117 million children in 37 countries, many of whom live in regions with ongoing measles outbreaks, could be impacted by the suspension of scheduled immunisation activities," Measles and Rubella Initiative (M & RI) said in a statement.New WHO guidelines endorsed by the Strategic Advisory Group of Experts on Immunisation aim to help countries to sustain immunisation activities during the COVID-19 pandemic."The @MeaslesRubella Initiative supports recommendations to: temporarily pause preventive immunisation campaigns where there's no active outbreak of a vaccine-preventable disease continue routine immunisation services, ..

Rafael Nadal says Novak Djokovic will need to be vaccinated to keep playing if the governing bodies of tennis make coronavirus shots obligatory once they become available. Nadal told the Spanish newspaper La Voz de Galicia this week that Djokovic and all players will have to follow the rules when tennis eventually returns to action. Nadal said no one can be forced to take the vaccine and everyone should be free to make their choices, but all players will have to comply if tennis officials require vaccination to travel and to protect everyone on the tour. Then Djokovic will have to be vaccinated if he wants to keep playing tennis at the top level, Nadal said. The same for me. Everyone will have to follow the rules, just like now we have to stay at home. Djokovic recently said he was against taking a vaccine for the coronavirus even if it became mandatory to travel. He later said he was open to changing his mind. If the ATP or the International Tennis Federation obligates us to take the

Just as democracy prevents famines without addressing everyday food scarcity, does it prevent horrendous violence while accepting and even abetting smaller acts of violence, wonders Rajesh Kasturirangan.

Serum, the world’s largest maker of vaccines by volume, is mass-producing the vaccine candidate developed by the University of Oxford.

The DRDO is making special N-99 masks, besides personal protective gear for chemical, biological, radiation and nuclear-related activities, and working on software, including one that will track people under quarantine.

They found almost 200 recurrent genetic mutations of the new coronavirus - SARS-CoV-2 - that show how it may be evolving as it spreads in people.

While Israel's defence ministry announced a breakthrough in the development of an antibody, Rome-based biotech firm Takis said vaccine tests had shown positive effects.

The drug developer had previously said it expected mid-stage trials to begin in the current quarter, with the aim to start late-stage studies in the fall.

Breast milk, the first vaccine, provides baby with essential nutrients, antibodies and factors that protect against infection.

Washington, May 4: President Donald Trump says he believes a vaccine for COVID-19 will be available by the end of the year. Trump also says the U.S. government is putting its "full power and might" behind remdesivir, a drug that has

Washington, May 4: Hundreds of people are rolling up their sleeves in countries across the world to be injected with experimental vaccines that might stop COVID-19, spurring hope - maybe unrealistic - that an end to the pandemic may arrive sooner

Washington, May 05: President Donald Trump says he believes a vaccine for COVID-19 will be available by the end of the year. Trump also says the US government is putting its full power and might behind remdesivir, a drug that has

The study that appeared in the pre-print repository medRxiv, proposed that national differences in COVID-19 impact could be partially explained by the different national policies respect to BCG childhood vaccination.

COVID-19 is currently the biggest, health and economic threat to the world. Researchers and scientists across the world are constantly making efforts to find its treatment and develop a vaccine to combat it. The biggest challenge in developing the vaccine

World Immunization Week is celebrated in the last week of April (24 to 30 April). Its main objective is to encourage the use of vaccines to protect people of all ages against diseases. Globally, Immunisation is considered a cost-effective public health

According to recent reports by WHO, there are 2,303,312 COVID-19 infected persons around the world, with 270,765 deaths. Researchers and health experts around the globe are ardently focused on studying the novel coronavirus, where new findings and understanding help in the

Experts largely expect the month of May to be a consolidation period though stock specific action could continue due to March quarter earnings.

The Indian benchmarks jumped nearly 3 percent on the closing of the long weekend for the market. The investors are still in hope for the stimulus package by the government.

According to recent reports by WHO, there are 2,303,312 COVID-19 infected persons around the world, with 270,765 deaths. Researchers and health experts around the globe are ardently focused on studying the novel coronavirus, where new findings and understanding help in the

Pfizer's chief scientific officer tells Reuters his company got a head start on vaccine development for the coronavirus because it had already been working for two years on the flu with its German partner, BioNTech. Fred Katayama reports.

Pfizer Inc said on Friday it is in talks to shift more of its medicine production to outside contractors as it prepares for large-scale production of an experimental vaccine to prevent COVID-19, should it prove safe and effective.

According to the World Health Organization, at present several coronavirus vaccines are in the development phase.

The researchers have reportedly managed to generate antibodies in mice that work on human cells.

Cham : Springer, 2020.

[S.l.] : SPRINGER NATURE, 2020.

Cham, Switzerland : Springer, [2019]

Interview with Michael E. Pichichero, MD, author of Combined Tetanus, Diphtheria, and 5-Component Pertussis Vaccine for Use in Adolescents and Adults, published in the June 22/29 issue of JAMA, the Journal of the American Medical Association. Summary Points: 1. Need: The combined tetanus-diphtheria 5-component pertussis vaccine is needed; There has been a 300% increase of pertussis among US adolescents in the last three years. 2. Safety: The combined tetanus-diphtheria 5-component pertussis vaccine is safe, as the reactions are the same as the tetanus vaccine. 3. Universal: On June 30, 2005, the American Academy of Pediatrics (ASAP), America Academy of Family Physicians (AFAR), and the Advisory Committee on Immunization Practices (ACID) all recommended the universal use of the combined tetanus-diphtheria 5-component pertussis vaccine or its competitor vaccine for adolescents.

This Viewpoint proposes a framework for international cooperation among governments and organizations to replace competition and hoarding with equitable global distribution of COVID-19 therapeutics and vaccines as they are developed.

Navin, Mark, author

Chinese scientists have claimed that they have successfully tested the country's first vaccine against Covid-19 on monkeys, which is a significant development in the race to find a cure for the virus. According to the reports, PiCoVacc, an inactivated Covid-19 vaccine candidate made by Beijing-based Sinovac Biotech, has shown promising results.

With China having largely curbed its growth of new infections, its drugmakers will need to seek international cooperation to test their vaccine candidates in other countries — a task that may be complicated by tensions between China and some nations, especially the US, over how and where the virus originated.

A few of them are expected to move into clinical trials later this year.

Italy says it has developed world's first COVID-19 vaccine

French drugmaker Sanofi SA said it plans to enroll thousands of subjects globally for trials of an experimental vaccine for the coronavirus it is developing with GlaxoSmithKline Plc, and that it has started to discuss advanced purchases with several countries. Sanofi teamed with British rival GSK to come up with a candidate it hopes will be ready next year.

Online Resource

Vaccine Alert From Walene James

Andrea Marzi discusses a vaccine that is effective against Ebola in monkeys and David Grimm talks about weigh-loss surgery, carbon suckers, and sexist HVAC. Hosted by Sarah Crespi. [Img: NIAID]

This week, we chat about what it means if a monkey can learn to recognize itself in a mirror, injecting people with live malaria parasites as a vaccine strategy, and insect-inspired wind turbines with Online News Editor David Grimm. And Joleah Lamb joins Alexa Billow to discuss how seagrass can greatly reduce harmful microbes in the ocean—protecting people and corals from disease. Read the research.   Listen to previous podcasts.   [Image: peters99/iStock; Music: Jeffrey Cook]

Strawberries had both male and female parts, like most plants, until several million years ago. This may seem like a long time ago, but it actually means strawberries have some of the youngest sex chromosomes around. What are the advantages of splitting a species into two sexes? Host Sarah Crespi interviews freelance journalist Carol Cruzan Morton about her story on scientists’ journey to understanding the strawberry’s sexual awakening. In 2016, experimental Zika vaccines were swiftly developed in response to the emergence of serious birth defects in the babies of infected woman. Two years after the height of Zika cases, there’s so little spread of the virus in the Americas that it has stymied vaccine trials. Researchers hope to overcome this hurdle with “human challenge experiments”—vaccinating people, then intentionally infecting them with Zika to see whether they’re protected from the virus. Meagan Cantwell talks with staff writer Jon Cohen about his news story that highlights the risks and rewards of human challenge experiments. This week’s episode was edited by Podigy. Download a transcript of this episode (PDF) Listen to previous podcasts. About the Science Podcast [Image: Public domain; Music: Jeffrey Cook]